ArticleInternational journal of oncology2018

CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.

Peng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.